1. Academic Validation
  2. Mutations in topoisomerase IIβ result in a B cell immunodeficiency

Mutations in topoisomerase IIβ result in a B cell immunodeficiency

  • Nat Commun. 2019 Aug 13;10(1):3644. doi: 10.1038/s41467-019-11570-6.
Lori Broderick 1 2 Shawn Yost 3 4 Dong Li 5 Matthew D McGeough 3 6 Laela M Booshehri 3 Marisela Guaderrama 3 Susannah D Brydges 7 Karolina Kucharova 8 Niraj C Patel 9 Margaret Harr 10 11 Hakon Hakonarson 5 11 Elaine Zackai 10 11 Ian G Cowell 12 Caroline A Austin 12 Boris Hügle 13 Corinna Gebauer 14 Jianguo Zhang 15 16 Xun Xu 15 16 Jian Wang 15 16 Ben A Croker 3 Kelly A Frazer 3 17 18 Christopher D Putnam 6 19 Hal M Hoffman 3 17 6
Affiliations

Affiliations

  • 1 Department of Pediatrics, University of California at San Diego, La Jolla, CA, 92093, USA. lbroderick@ucsd.edu.
  • 2 Rady Children's Hospital of San Diego, San Diego, CA, 92123, USA. lbroderick@ucsd.edu.
  • 3 Department of Pediatrics, University of California at San Diego, La Jolla, CA, 92093, USA.
  • 4 Division of Genetics and Epidemiology, Institute of Cancer Research, London, SM2 5NG, UK.
  • 5 Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
  • 6 Department of Medicine, University of California at San Diego, La Jolla, CA, 92093, USA.
  • 7 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 10591, USA.
  • 8 Laboratory of Molecular Immunology, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92093, USA.
  • 9 Department of Pediatrics, Levine Children's Hospital, Atrium Health, Charlotte, NC, 28203, USA.
  • 10 Department of Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
  • 11 Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, 19104, USA.
  • 12 Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • 13 German Center for Pediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, 82467, Germany.
  • 14 Division of Neonatology, University Hospital for Children and Adolescents, University of Leipzig, Leipzig, 04109, Germany.
  • 15 BGI-Shenzhen, Beishan Industrial Zone, Shenzhen, 518083, China.
  • 16 China National GeneBank, BGI-Shenzhen, Jinsha Road, Shenzhen, 518120, China.
  • 17 Rady Children's Hospital of San Diego, San Diego, CA, 92123, USA.
  • 18 Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
  • 19 San Diego Branch, Ludwig Institute of Cancer Research, La Jolla, CA, 92093, USA.
Abstract

B cell development is a highly regulated process involving multiple differentiation steps, yet many details regarding this pathway remain unknown. Sequencing of patients with B cell-restricted immunodeficiency reveals autosomal dominant mutations in TOP2B. TOP2B encodes a type II Topoisomerase, an essential gene required to alleviate topological stress during DNA replication and gene transcription, with no previously known role in B cell development. We use Saccharomyces cerevisiae, and knockin and knockout murine models, to demonstrate that patient mutations in TOP2B have a dominant negative effect on Enzyme function, resulting in defective proliferation, survival of B-2 cells, causing a block in B cell development, and impair humoral function in response to immunization.

Figures